NasdaqGS:MDRX

Stock Analysis Report

Allscripts Healthcare Solutions

Executive Summary

Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally.

Snowflake

Fundamentals

Moderate growth potential and slightly overvalued.

Risks

  • Allscripts Healthcare Solutions has significant price volatility in the past 3 months.

Similar Companies

Share Price & News

How has Allscripts Healthcare Solutions's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-1.3%

NasdaqGS:MDRX

0.5%

US Healthcare Services

0.2%

US Market


1 Year Return

-37.8%

NasdaqGS:MDRX

14.6%

US Healthcare Services

-0.7%

US Market

MDRX underperformed the Healthcare Services industry which returned 16% over the past year.

MDRX underperformed the Market in United States of America which returned 0.3% over the past year.


Share holder returns

MDRXIndustryMarket
7 Day-1.3%0.5%0.2%
30 Day-16.3%-2.2%-2.7%
90 Day-12.3%4.3%1.6%
1 Year-37.8%-37.8%14.7%14.6%1.6%-0.7%
3 Year-29.0%-29.0%53.4%53.0%40.0%30.9%
5 Year-38.5%-38.5%56.3%55.3%53.8%36.8%

Price Volatility Vs. Market

How volatile is Allscripts Healthcare Solutions's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Allscripts Healthcare Solutions undervalued based on future cash flows and its price relative to the stock market?

29%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Allscripts Healthcare Solutions's share price is below the future cash flow value, and at a moderate discount (> 20%).

Allscripts Healthcare Solutions's share price is below the future cash flow value, but not at a substantial discount (< 40%).


Price Based on Earnings

Allscripts Healthcare Solutions is loss making, we can't compare its value to the US Healthcare Services industry average.

Allscripts Healthcare Solutions is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Allscripts Healthcare Solutions, we can't assess if its growth is good value.


Price Based on Value of Assets

Allscripts Healthcare Solutions is good value based on assets compared to the US Healthcare Services industry average.


Next Steps

Future Growth

How is Allscripts Healthcare Solutions expected to perform in the next 1 to 3 years based on estimates from 16 analysts?

74.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Allscripts Healthcare Solutions's revenue is expected to grow by 5.4% yearly, however this is not considered high growth (20% yearly).

Allscripts Healthcare Solutions's earnings are expected to grow significantly at over 20% yearly.

Allscripts Healthcare Solutions's revenue growth is positive but not above the United States of America market average.

Allscripts Healthcare Solutions's earnings growth is expected to exceed the United States of America market average.

Allscripts Healthcare Solutions's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Allscripts Healthcare Solutions is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has Allscripts Healthcare Solutions performed over the past 5 years?

-3.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Allscripts Healthcare Solutions does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Allscripts Healthcare Solutions's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Allscripts Healthcare Solutions's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Allscripts Healthcare Solutions has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Allscripts Healthcare Solutions has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Allscripts Healthcare Solutions improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Allscripts Healthcare Solutions's financial position?


Financial Position Analysis

Allscripts Healthcare Solutions's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Allscripts Healthcare Solutions's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

Allscripts Healthcare Solutions's level of debt (64.2%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has increased over the past 5 years (43% vs 64.2% today).


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 1x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Allscripts Healthcare Solutions has less than a year of cash runway based on current free cash flow.

Allscripts Healthcare Solutions has less than a year of cash runway if free cash flow continues to grow at historical rates of 80.6% each year.


Next Steps

Dividend

What is Allscripts Healthcare Solutions's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Allscripts Healthcare Solutions's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Allscripts Healthcare Solutions's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Allscripts Healthcare Solutions has not reported any payouts.

Unable to verify if Allscripts Healthcare Solutions's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Allscripts Healthcare Solutions has not reported any payouts.


Future Payout to Shareholders

No need to calculate the sustainability of Allscripts Healthcare Solutions's dividends in 3 years as they are not expected to pay a notable one for United States of America.


Next Steps

Management

What is the CEO of Allscripts Healthcare Solutions's salary, the management and board of directors tenure and is there insider trading?

2.1yrs

Average management tenure


CEO

Paul Black (61yo)

6.7yrs

Tenure

US$7,801,251

Compensation

Mr. Paul M. Black has been the Chief Executive Officer of Allscripts Healthcare Solutions, Inc. since December 19, 2012. Mr. Black serves as an Adjunct Professor of Businss at the University of Missouri –  ...


CEO Compensation Analysis

Paul's remuneration is higher than average for companies of similar size in United States of America.

Paul's compensation has increased whilst company is loss making.


Management Age and Tenure

2.1yrs

Average Tenure

54yo

Average Age

The tenure for the Allscripts Healthcare Solutions management team is about average.


Board Age and Tenure

3.3yrs

Average Tenure

62.5yo

Average Age

The tenure for the Allscripts Healthcare Solutions board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

BuyUS$99,84117 Dec 18
Jonathan Judge
EntityIndividual
Role
Member of the Board of Directors
Director
Shares9,622
Max PriceUS$10.38
BuyUS$10,00617 Dec 18
Mara Aspinall
EntityIndividual
Role
Member of the Board of Directors
Director
Shares963
Max PriceUS$10.39
BuyUS$9,79817 Dec 18
P. Garrison
EntityIndividual
Role
Member of the Board of Directors
Director
Shares1,000
Max PriceUS$9.80
SellUS$589,23314 Dec 18
Richard Poulton
EntityIndividual
Role
President
President
Shares60,000
Max PriceUS$9.86
BuyUS$250,02713 Dec 18
Paul Black
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares24,765
Max PriceUS$10.10
BuyUS$120,84013 Dec 18
Yancey Spruill
EntityIndividual
Role
Member of the Board of Directors
Director
Shares12,000
Max PriceUS$10.07

Ownership Breakdown


Management Team

  • Paul Black (61yo)

    CEO & Director

    • Tenure: 6.7yrs
    • Compensation: US$7.80m
  • Rick Poulton (54yo)

    President

    • Tenure: 3.8yrs
    • Compensation: US$5.50m
  • Stephen Shulstein

    Vice President of Investor Relations

    • Tenure: 1.2yrs
  • Paul Lewis

    Senior Vice President of Sales & Services and Acting General Manager

    • Tenure: 12.6yrs
  • Rich Elmore

    Senior Vice President of Corporate Development & Strategy

    • Tenure: 0.6yrs
  • Dennis Olis (56yo)

    Chief Financial Officer

    • Tenure: 2.3yrs
    • Compensation: US$2.50m
  • Brian Farley (49yo)

    Executive VP

    • Tenure: 2.0yrs
    • Compensation: US$2.92m
  • Lisa Khorey (52yo)

    Executive VP & Chief Client Delivery Officer

    • Tenure: 2.8yrs
    • Compensation: US$2.98m
  • Ann Beasley

    Senior VP & Chief Marketing Officer

    • Tenure: 0.6yrs
  • Leah Jones

    Senior Vice President of Sales Operations

    • Tenure: 0.6yrs

Board Members

  • David Stevens (65yo)

    Director

    • Tenure: 7.6yrs
    • Compensation: US$303.00k
  • Paul Black (61yo)

    CEO & Director

    • Tenure: 6.7yrs
    • Compensation: US$7.80m
  • Jon Judge (65yo)

    Director

    • Tenure: 3.3yrs
    • Compensation: US$294.40k
  • Michael Klayko (64yo)

    Chairman of the Board

    • Tenure: 5.4yrs
    • Compensation: US$427.75k
  • Yancey Spruill (51yo)

    Director

    • Tenure: 3.3yrs
    • Compensation: US$273.00k
  • Dave Stevens (56yo)

    Director

    • Tenure: 3.3yrs
    • Compensation: US$271.50k
  • Mara Aspinall (57yo)

    Director

    • Tenure: 2.3yrs
    • Compensation: US$274.50k
  • Greg Garrison (65yo)

    Director

    • Tenure: 4.1yrs
    • Compensation: US$304.50k
  • John Sage

    Senior Vice President of U.S. Hospitals & Health Systems Sales

    • Tenure: 1.6yrs

Company Information

Allscripts Healthcare Solutions, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Allscripts Healthcare Solutions, Inc.
  • Ticker: MDRX
  • Exchange: NasdaqGS
  • Founded: 1986
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$1.527b
  • Shares outstanding: 166.65m
  • Website: https://www.allscripts.com

Number of Employees


Location

  • Allscripts Healthcare Solutions, Inc.
  • 222 Merchandise Mart Plaza
  • Suite 2024
  • Chicago
  • Illinois
  • 60654
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MDRXNasdaqGS (Nasdaq Global Select)YesCommon SharesUSUSDMar 2006
AL21DB (Deutsche Boerse AG)YesCommon SharesDEEURMar 2006

Biography

Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health recor ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/20 23:32
End of Day Share Price2019/08/20 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.